Australia markets closed

Jaguar Health, Inc. (JAGX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.2200-0.0700 (-1.63%)
At close: 04:00PM EDT
4.2900 +0.07 (+1.66%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 20.63M
Enterprise value 42.42M
Trailing P/E 0.13
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.43
Price/book (mrq)1.72
Enterprise value/revenue 4.18
Enterprise value/EBITDA -0.74

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-88.14%
S&P500 52-week change 323.49%
52-week high 343.2000
52-week low 33.0600
50-day moving average 39.5812
200-day moving average 312.7609

Share statistics

Avg vol (3-month) 31.25M
Avg vol (10-day) 31.25M
Shares outstanding 54.89M
Implied shares outstanding 64.96M
Float 84.58M
% held by insiders 17.38%
% held by institutions 11.99%
Shares short (15 May 2024) 4211.76k
Short ratio (15 May 2024) 40.14
Short % of float (15 May 2024) 44.33%
Short % of shares outstanding (15 May 2024) 44.33%
Shares short (prior month 15 Apr 2024) 4239.35k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 307 June 2019
Ex-dividend date 4N/A
Last split factor 21:60
Last split date 323 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-349.43%

Management effectiveness

Return on assets (ttm)-35.94%
Return on equity (ttm)-353.98%

Income statement

Revenue (ttm)10.14M
Revenue per share (ttm)9.89
Quarterly revenue growth (yoy)19.20%
Gross profit (ttm)N/A
EBITDA -30.28M
Net income avi to common (ttm)-38.32M
Diluted EPS (ttm)32.4000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.67M
Total cash per share (mrq)2.39
Total debt (mrq)33.45M
Total debt/equity (mrq)233.90%
Current ratio (mrq)1.89
Book value per share (mrq)2.63

Cash flow statement

Operating cash flow (ttm)-30.34M
Levered free cash flow (ttm)-18.39M